No Pharma Money
All News & Reports

News

The week in prescription drug pricing: what moved, what it means for patients, and what comes next.

Stay Up To Date

News and reports from P4ADNow

News Mar 16, 2023

ICYMI: Patient Advocate Ginny Boynton Meets With President Biden To Share How The Inflation Reduction Act Will Lower Drug Costs For Patients

Ginny Boynton, a retired lawyer and advocate with Patients For Affordable Drugs Now, met with President Biden last week to share how the Inflation Reduction Act will lower her drug costs.

Read Article
News Mar 11, 2023

The Week in Review in Prescription Drug Pricing

Thank you to the mother of the disability rights movement, Judy Heumann, for a lifetime of relentless activism.

Read Article
News Mar 9, 2023

Comments of Patients For Affordable Drugs Now to The Centers For Medicare & Medicaid Services on the Implementation of the Medicare Prescription Drug Inflation Rebate Program under The Inflation Reduction Act of 2022

P4ADNow-MPDIRP-Comments-March-2023

Read Article
News Mar 6, 2023

The Week in Review in Prescription Drug Pricing

Too soon: Cherry blossom peak bloom?. Not soon enough: Eli Lilly’s insulin price reduction?.

Read Article
News Feb 25, 2023

The Week in Review in Prescription Drug Pricing

Just like Angela Bassett, the Senate Judiciary Committee did the thing, and passed five bipartisan bills to help fix key elements of our rigged drug price system.

Read Article
News Feb 17, 2023

ICYMI: P4ADNow In The News – Debunking Big Pharma, Fighting For Future Reforms, And Celebrating Recent Wins

Happy Friday! Here’s a quick media roundup featuring P4ADNow leaders and patient advocates in the news this week fighting for lower drug prices

Read Article
News Feb 11, 2023

The Week in Review in Prescription Drug Pricing

For the price of a month’s supply of blood cancer drug Revlimid, you could buy two tickets to the Super Bowl AND 11 tickets to Beyoncé’s upcoming Renaissance Tour.

Read Article
News Feb 4, 2023

The Week in Review in Prescription Drug Pricing

AbbVie’s blockbuster drug Humira faces biosimilar competition for the first time in the drug’s 20-year reign in the United States.

Read Article
News Jan 28, 2023

The Week in Review in Prescription Drug Pricing

The drug price reforms in the Inflation Reduction Act are continuing to provide much-needed relief to patients.

Read Article
News Jan 21, 2023

The Week in Review in Prescription Drug Pricing

Happy Lunar New Year! May the year of the rabbit bring you peace, longevity, prosperity, and lower drug prices?

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.